Manufacturer record
GlaxoSmithKline Pharma Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by GlaxoSmithKline Pharma Ltd (Goa) were declared Not of Standard Quality between October 2019 and December 2021. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
2 records linked to GlaxoSmithKline Pharma Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Betamethasone Valerate and Neomycin Skin Cream (BETNOVATE-N CREAM) | FC989Mfg 2021-05 · Exp 2022-10 | IdentificationIdentification | RDTL ChandigarhState lab | Dec 2021 |
| Betamethasone Valerate and Neomycin Skin Cream (BETNOVATE-N CREAM) | EZ277Mfg 2019-01 · Exp 2020-06 | Identification Betamethasone Valerate and Neomycin SulphateIdentification | RDTL ChandigarhState lab | Oct 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.